Drug Information

Drug General Information
Drug ID
D02MLO
Former ID
DIB000599
Drug Name
WT1-targeted autologous dendritic cell vaccine
Synonyms
Dendritic cell vaccine; WT1-targeted autologous dendritic cell vaccine (cancer)
Drug Type
Vaccine
Indication Acute myeloid leukemia [ICD9: 205; ICD10:C92.0] Phase 2 [524053]
Company
University of Antwerp; Argos Therapeutics Durham; NC Geron; Dendreon Seattle; WA; ImmunoCellular Therapeutics
Target and Pathway
Target(s) Wilms' tumor protein Target Info [524053]
KEGG Pathway Transcriptional misregulation in cancer
NetPath Pathway FSH Signaling Pathway
IL5 Signaling Pathway
Pathway Interaction Database p73 transcription factor network
Regulation of Telomerase
WikiPathways Primary Focal Segmental Glomerulosclerosis FSGS
Integrated Pancreatic Cancer Pathway
References
Ref 524053ClinicalTrials.gov (NCT01686334) Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission. U.S. National Institutes of Health.
Ref 524053ClinicalTrials.gov (NCT01686334) Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.